Wird geladen...
Erythroid-specific Human Factor IX Delivery From In Vivo Selected Hematopoietic Stem Cells Following Nonmyeloablative Conditioning in Hemophilia B Mice
We have developed a lentiviral vector system for human factor IX (hFIX) gene transfer in hematopoietic stem cells (HSCs) that provides erythroid cell-derived systemic protein delivery following nonmyeloablative conditioning and in vivo methylguanine methyltransferase (MGMT) drug selection. After bon...
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Artigo |
Sprache: | Inglês |
Veröffentlicht: |
2008
|
Schlagworte: | |
Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2658893/ https://ncbi.nlm.nih.gov/pubmed/18682698 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2008.161 |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|